Savara Inc Amortization of Debt Discount (Premium)
Savara Inc (SVRA) reported Amortization of Debt Discount (Premium) of $400.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2020-03-12
- Savara Inc amortization of debt discount (premium) for the quarter ending 2019-12-31 was $0.00.
- Savara Inc amortization of debt discount (premium) for the quarter ending 2019-09-30 was $0.00.
- Savara Inc amortization of debt discount (premium) for the quarter ending 2019-06-30 was $0.00.
- Savara Inc amortization of debt discount (premium) for the quarter ending 2019-03-31 was $400.00K, a 0.00% change year-over-year.
- Savara Inc amortization of debt discount (premium) for fiscal 2019 was $400.00K, a 0.00% change from fiscal 2018.
- Savara Inc amortization of debt discount (premium) for fiscal 2018 was $400.00K, a 0.00% change from fiscal 2017.
- Savara Inc amortization of debt discount (premium) for fiscal 2017 was $400.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 181 month | Amortization of Debt Discount (Premium) 184 month | Amortization of Debt Discount (Premium) 187 month | Amortization of Debt Discount (Premium) 190 month | Amortization of Debt Discount (Premium) 193 month | Amortization of Debt Discount (Premium) 196 month | Amortization of Debt Discount (Premium) 199 month | Amortization of Debt Discount (Premium) 202 month | Amortization of Debt Discount (Premium) 205 month | Amortization of Debt Discount (Premium) 208 month | Amortization of Debt Discount (Premium) 211 month | Amortization of Debt Discount (Premium) 214 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $0.00 derived: sum of 2 quarters · filed 2020-03-12 | $0.00 derived: sum of 3 quarters · filed 2020-03-12 | $400.00K 10-K · filed 2020-03-12 | ||||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $400.00K 10-Q · filed 2019-11-07 | $400.00K derived: sum of 4 quarters · filed 2019-11-07 | ||||||||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $400.00K 10-Q · filed 2019-08-08 | $400.00K derived: sum of 3 quarters · filed 2019-08-08 | $400.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||||
| 2019-03-31 | $400.00K 10-Q · filed 2019-05-09 | $400.00K derived: sum of 2 quarters · filed 2019-05-09 | $400.00K derived: sum of 3 quarters · filed 2019-05-09 | $400.00K derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | $400.00K 10-K · filed 2019-03-13 | ||||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $400.00K 10-Q · filed 2018-11-07 | $400.00K derived: sum of 4 quarters · filed 2018-11-07 | ||||||||||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $400.00K 10-Q · filed 2018-08-09 | $400.00K derived: sum of 3 quarters · filed 2018-08-09 | $400.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||
| 2018-03-31 | $400.00K 10-Q · filed 2018-05-09 | $400.00K derived: sum of 2 quarters · filed 2018-05-09 | $400.00K derived: sum of 3 quarters · filed 2018-05-09 | |||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $400.00K 10-K · filed 2018-03-14 | |||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $400.00K 10-Q · filed 2017-11-08 | ||||||||||||||
| 2017-06-30 | $400.00K 10-Q · filed 2017-08-09 | |||||||||||||||
| 2014-03-31 | $450.00K 10-Q · filed 2014-05-05 | |||||||||||||||
| 2013-12-31 | $450.00K 10-K · filed 2014-03-26 | |||||||||||||||
| 2013-09-30 | $450.00K 10-Q · filed 2013-11-04 | |||||||||||||||
| 2013-06-30 | $450.00K 10-Q · filed 2013-08-05 | |||||||||||||||
| 2013-03-31 | $450.00K 10-Q · filed 2013-05-15 | |||||||||||||||
| 2012-12-31 | $450.00K 10-K · filed 2013-03-19 | |||||||||||||||
| 2012-09-30 | $450.00K 10-Q · filed 2012-11-05 | |||||||||||||||
| 2012-06-30 | $450.00K 10-Q · filed 2012-08-06 | |||||||||||||||
| 2012-03-31 | $450.00K 10-Q · filed 2012-05-07 | |||||||||||||||
| 2011-12-31 | $450.00K 10-K · filed 2012-03-08 | |||||||||||||||
| 2011-09-30 | $450.00K 10-Q · filed 2011-11-08 | |||||||||||||||
| 2011-06-30 | $450.00K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |